Bausch Health Companies | VRX - Ordinary Share Capital


Bausch Health Companies reported $373.46M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Amgen USD 540M 1000K Mar/2026
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
Bausch Health Companies USD 373.46M 2.93M Mar/2026
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Danaher USD 707.7M 800K Mar/2026
Drreddys Laboratories INR 832.57M 53K Dec/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
Gilead Sciences USD 1.24B 1000K Mar/2026
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Novo Nordisk DKK 4.44B 0 Dec/2025
Pacira USD 39.31M 1.81M Mar/2026
Perrigo USD 138.1M 500K Mar/2026
Phibro Animal Health USD 40.48M 0 Dec/2025
Prestige Brands USD 47.32M 765K Dec/2025
Supernus Pharmaceuticals USD 58.04M 582K Mar/2026
Vertex Pharmaceuticals USD 254.2M 200K Mar/2026
Zoetis USD 420.35M 4.58M Mar/2026